Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Articles by Melville Hodge
Let’s get rid of the dialysis death incentive - Nephrology News & Issues
We often look to medical research to enhance the quality of life and survival of dialysis patients. But in striving toward those goals we must not ignore the role that financial incentives—or disincentives—play in the major for-profit industry that dialysis care has become. The principal revenue source for this industry in the United States is Medicare.
State renal associations: We can make a difference - Nephrology News & Issues
Getty Images/iStockphoto/ThinkStock Next month, NN&I readers will have the opportunity to vote for a new leader of the United States. It may be hard to disseminate Donald Trump’s or Hilary Clinton’s views on Medicare funding for the End-Stage Renal Disease Program, but you can find out where your state political leadership stands by getting involved in your local renal association. It is an opportunity to help your industry and your patients.
Fresenius Medical Care to provide renal care for Collaborative Health Systems ACOs - Nephrology News & Issues
Fresenius Medical Care to provide renal care for Collaborative Health Systems ACOs Fresenius Medical Care will provide integrated health care management for patients with renal disease who are enrolled in seven Medicare Shared Savings Program Accountable Care Organizations (MSSP ACOs) operated by Collaborative Health Systems and physician partners, the dialysis provider announced October 26.
American Kidney Fund creates safeguards for its Health Insurance Premium Program - Nephrology News & Issues
The American Kidney Fund said that it has created new safeguards to protect patients’ autonomy and informed choice when they turn to AKF’s Health Insurance Premium Program (HIPP) for help affording insurance coverage. AKF said it currently educates grant recipients about the HIPP program with a program guidelines document and a quarterly patient newsletter.
CMS fixes error code, but payment catch-up for dialysis providers will last through November - Nephrology News & Issues
CMS fixes error code, but payment catch-up for dialysis providers will last through November Getty Images/Wavebreak Media/ThinkStock The Centers for Medicare & Medicaid Services has begun processing claims rejected earlier this month due to an error code in its Outpatient Prospective Payment System, but dialysis providers won’t see all the delayed payments until next month. The National Renal Administrators Association first told its members on Oct. 11 that CMS’ effort to implement an Oct.
Analysis: Comorbidities, not sex, reason for higher AKI risk in women after heart surgery - Nephrology News & Issues
Analysis: Comorbidities, not sex, reason for higher AKI risk in women after heart surgery A new analysis indicates that women do not have a higher risk than men for developing kidney damage after cardiovascular surgery when adjustments are made for comorbidities A new analysis indicates that women do not have a higher risk than men for developing kidney damage after cardiovascular surgery when adjustments are made for comorbidities.
American Kidney Fund launches campaign to help new dialysis patients adjust to treatment - Nephrology News & Issues
American Kidney Fund launches campaign to help new dialysis patients adjust to treatment Hongqi Zhang/Getty Images/iStockphoto/ThinkStock The American Kidney Fund has started an education campaign that provides information for people newly diagnosed with kidney failure, their caregivers, and the professionals involved in their treatment. The campaign, called “FIRST30,”focuses on the first 30 days of dialysis treatment.
FDA to review new NDA for AstraZeneca’s hyperkalemia drug - Nephrology News & Issues
The U.S. Food and Drug Administration has accepted for review AstraZeneca's re-submission of a new drug application for the hyperkalemia drug sodium zirconium cyclosilicate. The FDA has indicated that this is a complete class 2 response. AstraZeneca announced in May that the FDA had rejected the new drug application for ZS-9 due to observations arising from a pre-approval manufacturing inspection.
American Kidney Fund activates disaster relief program to help dialysis patients affected by Hurricane Matthew - Nephrology News & Issues
American Kidney Fund activates disaster relief program to help dialysis patients affected by Hurricane Matthew Dialysis patients affected by Hurricane Matthew eligible for financial assistance from American Kidney Fund The American Kidney Fund has activated its disaster relief program to provide emergency funds to help dialysis patients in Florida, Georgia and the Carolinas.
FDA to review new NDA for AstraZeneca’s hyperkalemia drug - Nephrology News & Issues
The U.S. Food and Drug Administration has accepted for review AstraZeneca's re-submission of a new drug application for the hyperkalemia drug sodium zirconium cyclosilicate (ZS-9). The FDA has indicated that this is a complete class 2 response. AstraZeneca announced in May that the FDA had rejected the new drug application for ZS-9 due to observations arising from a pre-approval manufacturing inspection.
Quality will improve if we pay for dialysis based on time - Nephrology News & Issues
Why do American dialysis patients, living in the most scientifically advanced and prosperous country in the world, still face a double-digit risk of death? While mortality rates have declined among the prevalent population, 17% of patients still die each year, and half will die in less than four years. One out of five deaths will be from deliberate withdrawals from dialysis, according to U.S. Renal Data System data (2015).
Show More
loading
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Melville
Contact Melville, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack